Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Marso

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Circulation|May 16, 2018
Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER TrialSubodh Verma, Deepak L Bhatt, Stephen C Bain, et al.
Journal of Hypertension|February 9, 2016
LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trialJohn R Petrie, Steven P Marso, Stephen C Bain, et al.
Circulation. Cardiovascular Quality and Outcomes|May 12, 2016
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG)Ambarish Pandey, Darren K McGuire, James A de Lemos, et al.
Obesity (Silver Spring, Md.)|December 11, 2022
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristicsIldiko Lingvay, Kirstine Brown-Frandsen, Helen M Colhoun, et al.
Diabetologia|September 16, 2017
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortalityThomas R Pieber, Steven P Marso, Darren K McGuire, et al.
The New England Journal of Medicine|June 14, 2016
Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesSteven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, et al.
JACC. Cardiovascular Interventions|July 1, 2019
A Detailed Analysis of Perforations During Chronic Total Occlusion AngioplastyTaishi Hirai, William J Nicholson, James Sapontis, et al.
Coronary Artery Disease|October 19, 2016
The Outcomes, Patient Health Status, and Efficiency IN Chronic Total Occlusion Hybrid Procedures registry: rationale and designJames Sapontis, Steven P Marso, David J Cohen, et al.
JACC. Cardiovascular Imaging|March 17, 2012
Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromesSorin J Brener, Gary S Mintz, Ecaterina Cristea, et al.
American Heart Journal|February 16, 2010
Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasoundTakashi Kubo, Akiko Maehara, Gary S Mintz, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Circulation|May 16, 2018
Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER TrialSubodh Verma, Deepak L Bhatt, Stephen C Bain, et al.
Journal of Hypertension|February 9, 2016
LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trialJohn R Petrie, Steven P Marso, Stephen C Bain, et al.
Circulation. Cardiovascular Quality and Outcomes|May 12, 2016
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG)Ambarish Pandey, Darren K McGuire, James A de Lemos, et al.
Obesity (Silver Spring, Md.)|December 11, 2022
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristicsIldiko Lingvay, Kirstine Brown-Frandsen, Helen M Colhoun, et al.
Diabetologia|September 16, 2017
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortalityThomas R Pieber, Steven P Marso, Darren K McGuire, et al.
The New England Journal of Medicine|June 14, 2016
Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesSteven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, et al.
JACC. Cardiovascular Interventions|July 1, 2019
A Detailed Analysis of Perforations During Chronic Total Occlusion AngioplastyTaishi Hirai, William J Nicholson, James Sapontis, et al.
Coronary Artery Disease|October 19, 2016
The Outcomes, Patient Health Status, and Efficiency IN Chronic Total Occlusion Hybrid Procedures registry: rationale and designJames Sapontis, Steven P Marso, David J Cohen, et al.
JACC. Cardiovascular Imaging|March 17, 2012
Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromesSorin J Brener, Gary S Mintz, Ecaterina Cristea, et al.
American Heart Journal|February 16, 2010
Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasoundTakashi Kubo, Akiko Maehara, Gary S Mintz, et al.
Pageof 15